QA: Cell Source Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001569340_2022_Cell_Source_Inc.pdf

Logs

warning Similarly named company. Duplicate? None {'details': [{'other_company': 'International Stem Cell CORP', 'shared_tokens': {'cell'}}]}
warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001569340')"}

Graph

Absolute values for 0001569340, Cell Source Inc.

  xvar xval
0 AssetsCurrent 313,767
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 10,139,902
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,695,164
9 ResearchAndDevelopmentExpense 1,273,352
10 remainder_Expenses 50,056
11 remainder_Revenues 0
12 remainder_NetIncome -1,453,863
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 313,767
1 Liabilities 10,139,902
2 Expenses 4,018,572
3 Revenues 0
4 StockholdersEquity -9,826,135
5 NetIncome -5,472,435
6 ComprehensiveNetIncome -5,472,435
7 BaseVar 7,963,052
8 EconomicCapitalRatio -4.28

Edgar->Model Mapping

Feature Distribution

Change over Time